{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1686421", "DateCompleted": {"Year": "1992", "Month": "04", "Day": "01"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["ita"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0393-1978", "JournalIssue": {"Volume": "36", "Issue": "7", "PubDate": {"Year": "1991", "Month": "Jul"}}, "Title": "Cardiologia (Rome, Italy)", "ISOAbbreviation": "Cardiologia"}, "ArticleTitle": "[Neurohumoral changes in patients with heart failure treated chronically with beta-blockers].", "Pagination": {"StartPage": "549", "EndPage": "556", "MedlinePgn": "549-56"}, "Abstract": {"AbstractText": ["Long-term beta-blocker therapy may be useful in some patients affected by chronic heart failure. In a group of 15 patients with chronic heart failure of different origin we evaluated clinical, hemodynamic and neurohormonal features after 1 year of therapy. All patients were treated with atenolol at dosage of 50 mg/die. We observed a better ejection fraction by radionuclide angiography after 1 year of treatment. There was an increase of exercise time and VO2 max evaluated by cycloergometer test. There was a decrease of mean pulmonary artery pressure, of pulmonary vascular resistance and of right atrial pressure. Plasmatic norepinephrine decreased from 1294 +/- 568 to 574 +/- 33 pg/l. Our results suggest that patients who well tolerated chronic beta-blockade show an improvement of performance parameters."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cattedra di Malattie Cardiovascolari, Universit\u00e0 degli Studi, Modena."}], "LastName": "Mattioli", "ForeName": "A V", "Initials": "AV"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mattioli", "ForeName": "G", "Initials": "G"}], "PublicationTypeList": ["English Abstract", "Journal Article"], "VernacularTitle": "Modificazioni neurormonali in pazienti con insufficienza cardiaca trattata cronicamente con betabloccanti."}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Cardiologia", "NlmUniqueID": "8506637", "ISSNLinking": "0393-1978"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenergic beta-Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Diuretics"}, {"RegistryNumber": "0", "NameOfSubstance": "Neurotransmitter Agents"}, {"RegistryNumber": "50VV3VW0TI", "NameOfSubstance": "Atenolol"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Adrenergic beta-Antagonists"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Atenolol"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Diuretics"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": ["blood", "drug therapy", "physiopathology"], "DescriptorName": "Heart Failure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["blood"], "DescriptorName": "Neurotransmitter Agents"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1991", "Month": "7", "Day": "1"}, {"Year": "1991", "Month": "7", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1991", "Month": "7", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1686421"]}}]}